Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Tumor Mutations and VTE Risk – New Insights from a 12,500-Patient Cancer Study – JTH
First author of the article - Naomi Cornish/LinkedIn
Apr 6, 2026, 16:34

Tumor Mutations and VTE Risk – New Insights from a 12,500-Patient Cancer Study – JTH

Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Naomi Cornish et al, adding:

”Associations of Tumor Somatic Mutations with Cancer-Associated Venous Thromboembolism

Analysis of 12,507 cancer patients reveals that somatic mutations in CDKN2A, KRAS, PCDH15, and TP53 significantly increase VTE risk, while high tumor mutational burden is protective, offering novel insights into cancer-associated thrombosis pathophysiology and future risk prediction tools.”

Title: Associations of tumor somatic mutations with cancer-associated venous thromboembolism

Authors: Naomi Cornish, Rebecca Ward, Matthew T. Warkentin, Chrissie Thirlwell, Andrew D. Mumford, Sarah K. Westbury, Philip C. Haycock

Read the Full Article on JTH

Tumor Mutations and VTE Risk - New Insights from a 12,500-Patient Cancer Study - JTH

Stay updated on all scientific advances with Hemostasis Today.

Andrew D. Mumford cancer CAT Chrissie Thirlwell Health Hematology Hemostasis Hemostasis News Hemostasis Today JTH KRAS Matthew T. Warkentin Medicine n CDKN2A Naomi Cornish OncoDaily PCDH15 Philip C. Haycock Rebecca Ward Sarah K. Westbury thrombosis TP53 Tumor Somatic Mutations VTE
NewsFeed